Literature DB >> 31980111

Evolution of Diabetes Technology.

Klemen Dovc1, Tadej Battelino2.   

Abstract

Technological innovations have fundamentally changed diabetes care. Insulin pump use and continuous glucose monitoring are associated with improved glycemic control along with a better quality of life; automated insulin-dosing advisors facilitate and improve decision making. Glucose-responsive automated insulin delivery enables the highest targets for time in range, lowest rate and duration of hypoglycemia, and favorable quality of life. Clear targets for time in ranges and a standard visualization of the data will help the diabetes technology to be used more efficiently. Decision support systems within and integrated cloud environment will further simplify, unify, and improve modern routine diabetes care.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Artificial pancreas; Closed loop; Continuous glucose monitoring; Insulin pump; Multiple daily injections; Self-monitoring of blood glucose; Technology; Type 1 diabetes

Mesh:

Substances:

Year:  2019        PMID: 31980111     DOI: 10.1016/j.ecl.2019.10.009

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  7 in total

Review 1.  Friend or Foe: a Narrative Review of the Impact of Diabetes Technology on Sleep.

Authors:  Erin C Cobry; Angela J Karami; Lisa J Meltzer
Journal:  Curr Diab Rep       Date:  2022-05-06       Impact factor: 4.810

Review 2.  Closed-loop control in insulin pumps for type-1 diabetes mellitus: safety and efficacy.

Authors:  Julia Fuchs; Roman Hovorka
Journal:  Expert Rev Med Devices       Date:  2020-07-03       Impact factor: 3.166

Review 3.  Type 1 diabetes mellitus: much progress, many opportunities.

Authors:  Alvin C Powers
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

Review 4.  Technology in the management of type 2 diabetes: Present status and future prospects.

Authors:  Aideen Daly; Roman Hovorka
Journal:  Diabetes Obes Metab       Date:  2021-05-20       Impact factor: 6.408

5.  Autoimmune thyroiditis and celiac disease do not worsen endothelial function in subjects with type 1 diabetes: an observational study.

Authors:  Martina Parise; Antonio Cutruzzolà; Faustina Barbara Scavelli; Claudio Carallo; Agostino Gnasso; Concetta Irace
Journal:  Diabetol Metab Syndr       Date:  2022-07-23       Impact factor: 5.395

6.  Patient reported outcome measures in children and adolescents with type 1 diabetes using advanced hybrid closed loop insulin delivery.

Authors:  Ana Gianini; Jana Suklan; Brigita Skela-Savič; Simona Klemencic; Tadej Battelino; Klemen Dovc; Nataša Bratina
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-19       Impact factor: 6.055

Review 7.  The Evolution of Insulin and How it Informs Therapy and Treatment Choices.

Authors:  Irl B Hirsch; Rattan Juneja; John M Beals; Caryl J Antalis; Eugene E Wright
Journal:  Endocr Rev       Date:  2020-10-01       Impact factor: 19.871

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.